REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
30/06/2025
Voltar para busca
Dado oficial do USPTO
PRIMAVANT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
16
Atualização mais recente
01/07/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 36
Data de depósito
14/05/2019
Data de registro
30/06/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/06/2020
Última transação
01/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Basel, CH
Examinador
SIMCOX,KYLE DUNCAN
Unidade examinadora
N40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Primavant GmbH
Representantes
Allison Strickland Ricketts FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Classificação técnica
Classes Nice
Classe 35Classe 36
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business management; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; business advisory servicesconsultancy and information; market intelligence services in the pharmaceuticalbiopharmaceutical and healthcare industries; competitive intelligence services in the pharmaceuticalbiopharmaceutical and healthcare industries; professional business analysis and consultancy and statistical analysis for business purposes in the pharmaceuticalbiopharmaceutical and healthcare industries; providing information regarding market intelligence services and competitive intelligence services in the pharmaceuticalbiopharmaceutical and healthcare industries; compilation of data for business purposesanalysis of business data and professional business analysis in the pharmaceuticalbiopharmaceutical and healthcare industries; providing reimbursement benchmarking information and other market intelligence to healthcare organizations; collecting and professional business analysis of claims data from healthcare organizations for business purposes; business services provided to the pharmaceuticalbiopharmaceutical and healthcare industriesthe collectionreportingprofessional business analysis of healthcare and pharmaceutical data for business purposes; compiling data for business research and analysis purposes in the pharmaceuticalbiopharmaceutical and healthcare industries
Classe 36
Financial affairsfinancial informationmanagement and analysis services; monetary affairsfinancial informationmanagement and analysis services; capital investment; investment of funds; loans financing; financial evaluation for banking purposes; financing services; financial analysis; financial consulting; financial valuations and forecasting; financial analysiscompiling and analyzing statistics and data for financial purposes; financial analysis of investments in pharmaceuticalbiopharmaceutical and healthcare industries; providing financial services with respect to securities and other financial instruments and productstrading of and investments in securities and financial instruments and products for others; financial evaluationtrackinganalysisforecastingconsultancyadvisory and research services relating to securities and other financial instruments; research related to financial instruments
Publicações
Histórico de despachos e eventos da marca no USPTO.
16 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
30/06/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/04/2020
PUBO
PUBLISHED FOR OPPOSITION
14/04/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/02/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/02/2020
ALIE
ASSIGNED TO LIE
10/02/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/02/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/08/2019
GNRT
NON-FINAL ACTION E-MAILED
09/08/2019
CNRT
NON-FINAL ACTION WRITTEN
09/08/2019
DOCK
ASSIGNED TO EXAMINER
31/07/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/05/2019
NWAP
NEW APPLICATION ENTERED
17/05/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PRIMAVANT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.